Induction therapy prior to autologous stem cell transplantation (ASCT) in newly diagnosed multiple myeloma: an update

The current standard of care model for newly diagnosed fit multiple myeloma (NDMM) patients is the sequential treatment of induction, high dose melphalan, autologous stem cell transplantation (ASCT), and maintenance. Adequate induction is required to achieve good disease control and induce deep resp...

Descripción completa

Detalles Bibliográficos
Autores principales: Bazarbachi, Abdul Hamid, Al Hamed, Rama, Malard, Florent, Bazarbachi, Ali, Harousseau, Jean-Luc, Mohty, Mohamad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960754/
https://www.ncbi.nlm.nih.gov/pubmed/35347107
http://dx.doi.org/10.1038/s41408-022-00645-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960754/
https://www.ncbi.nlm.nih.gov/pubmed/35347107
http://dx.doi.org/10.1038/s41408-022-00645-1

Ejemplares similares